Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis
about
The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging BiomarkersSystematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directionsThree-dimensional quantitative assessment of lesion response to MR-guided high-intensity focused ultrasound treatment of uterine fibroids.3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?Image quality and diagnostic performance of free-breathing diffusion-weighted imaging for hepatocellular carcinoma.Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization.Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survivalIdentifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging MarkersEarly survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.MRI Findings and Prediction of Time to Progression of Patients with Hepatocellular Carcinoma Treated with Drug-eluting Bead Transcatheter Arterial Chemoembolization.Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement.Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.Hypo-Vascular Liver Metastases Treated with Transarterial chemoembolization: Assessment of Early Response by Volumetric Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance ImagingRenal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis.Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI.Hepatic imaging following intra-arterial embolotherapy.Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation.Intra-arterial therapies for liver cancer: assessing tumor response.Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates.Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.Risks factors for severe pain after selective liver transarterial chemoembolization.The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma.Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes UnderWhich Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?Multiparametric human hepatocellular carcinoma characterization and therapy response evaluation by hyperpolarized (13) C MRSI.Intravoxel incoherent motion MRI for monitoring the therapeutic response of hepatocellular carcinoma to sorafenib treatment in mouse xenograft tumor models.Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial Chemoembolization.Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review.Efficacy of radiofrequency ablation of hepatocellular carcinoma prior to liver transplantation and the need for competing-risk analysis
P2860
Q26768460-3DA96B69-D798-400E-8F12-D2D65F8AF89AQ27007847-ADC87B60-B0EB-4F8C-B25E-15AF09454B74Q30375041-27889B0F-2AA2-41AF-85F3-6A2FEC65EB0BQ30389621-94223CC2-27EE-481B-AB05-A06FE2FC2E9BQ33658301-FFF1F91C-1182-40C0-BA6D-40F9E39A8BE2Q33706727-C0550083-1874-4ECC-90DC-3F005FBFF015Q34369283-87491AE5-D915-4A43-8119-E2BC8683ABA4Q35044274-600E84C4-8B29-44BB-8C97-91F5E7B67C45Q35537007-56A3D4BA-3096-46CC-B868-F4B9504CB7E7Q35691040-C56B55BC-1311-470D-B11E-53D1A9D4CB5EQ35778627-1A83EB34-3C38-4E2C-9A56-5516DF2AC9FDQ36296750-EDB33553-DA0A-4A3F-9FD8-D1710B195154Q36304428-81AD662B-3B07-4C67-9766-ABC155C4E097Q36416250-30F08F9B-7F34-4A69-BB03-5FDBE073FE1CQ37088693-2C95EB3E-88A7-4A94-A9E2-5FEF48E22751Q37221919-09AA272F-5423-4B2C-8D0F-5003D45B3519Q37253841-E5892390-B269-4CED-94F3-EEC96E5EAB93Q38265114-2E0A7855-8444-4618-B0DB-C3E885650797Q38716483-7656E0DC-A3D8-4AAB-95D1-4F22F5BAC4FCQ38792625-82285074-ACF5-4517-9236-F5C6FAC87F6BQ39041266-514D6C0F-800C-4663-858C-EB559E1DB254Q42085639-4EBD19E7-760B-484F-ACA1-6426B84FDB81Q46013875-3958950D-F89F-4779-9B90-3DA2C46E2EDBQ47400891-DBCB221C-D49C-4D7F-B538-0968AE03EC91Q47967037-E15EDFB3-7A5A-466F-BFEE-7B5D5AA80DC4Q48346171-13ECECC6-A806-40B2-A635-B2A09417D607Q50223119-A3845DCA-6BD4-4A0C-881B-C6D67AE62893Q51326114-39364F81-9078-49DE-B803-38E1E422DB58Q52891816-9E08E0F7-730B-4102-B43C-A98DF467FE8CQ55312644-C4EEBA06-50C0-45A0-BEF6-0A71F25BB9F0Q55364224-B328C21F-1792-4C65-AE06-29A59A6857AAQ58804380-FDAC0EB9-D872-49A2-A97D-4B3C1779A8DB
P2860
Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Radiologic-pathologic analysis ...... 3D quantitative image analysis
@ast
Radiologic-pathologic analysis ...... 3D quantitative image analysis
@en
Radiologic-pathologic analysis ...... 3D quantitative image analysis
@nl
type
label
Radiologic-pathologic analysis ...... 3D quantitative image analysis
@ast
Radiologic-pathologic analysis ...... 3D quantitative image analysis
@en
Radiologic-pathologic analysis ...... 3D quantitative image analysis
@nl
prefLabel
Radiologic-pathologic analysis ...... 3D quantitative image analysis
@ast
Radiologic-pathologic analysis ...... 3D quantitative image analysis
@en
Radiologic-pathologic analysis ...... 3D quantitative image analysis
@nl
P2093
P2860
P356
P1433
P1476
Radiologic-pathologic analysis ...... 3D quantitative image analysis
@en
P2093
David Lesage
Ihab R Kamel
Jean-François Geschwind
Julius Chapiro
Laura D Wood
Lynn Jeanette Savic
MingDe Lin
Rafael Duran
Vania Tacher
Vivek Charu
P2860
P304
P356
10.1148/RADIOL.14140033
P407
P577
2014-07-15T00:00:00Z